Wacker Chemie AG/€WCH

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Wacker Chemie AG

Ticker

€WCH
Sector

Primary listing

XETRA

Industry

Chemicals
Headquarters

Employees

16,655

ISIN

DE000WCH8881

Wacker Chemie AG Metrics

BasicAdvanced
€3.5B
18.25
€3.81
1.13
€2.50
3.60%

What the Analysts think about Wacker Chemie AG

Analyst ratings (Buy, Hold, Sell) for Wacker Chemie AG stock.

Bulls say / Bears say

Wacker Chemie AG anticipates growth across all business divisions in 2025, projecting group sales between €6.1 billion and €6.4 billion, indicating a positive outlook despite previous market challenges. (pressetext.com)
The company's biotechnology division reported an 11% increase in sales in 2024, driven by growth in its biopharmaceutical business, suggesting a strong performance in this sector. (pressetext.com)
Wacker Chemie AG is expanding its biotechnology capabilities with a new center in Munich, aiming to boost biopharmaceutical and nutritional research, which could enhance future growth prospects. (webull.com)
In 2024, Wacker Chemie AG's EBITDA declined by 7% year-over-year to €770 million, primarily due to lower prices and sales volumes, particularly for solar-grade polysilicon, and high energy costs in Germany. (investing.com)
The polysilicon division experienced a 41% drop in sales compared to 2023, impacted by weakening demand for solar-grade polysilicon and sustained excess capacity in China, posing challenges to this segment. (investing.com)
Analysts have lowered price targets for Wacker Chemie AG, with Citi reducing it to €117 from €124, and JPMorgan adjusting it to €107 from €114, reflecting cautious sentiment due to uncertainties in the solar business and market environment. (nasdaq.com, nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Wacker Chemie AG Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Wacker Chemie AG Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €WCH

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs